Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
ConditionThymoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorFudan University
About this trial
This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- adjuvant radiotherapy
Treatment groups
238 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov